Frederick Baehner

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Metastatic balloon cell melanoma: a case report
    Frederick L Baehner
    Division of Cytopathology, University of California, San Francisco 94115, USA
    Acta Cytol 49:543-8. 2005
  2. ncbi Fine needle aspiration cytology of intraoral epithelioid hemangioma. A report of two cases
    Frederick Baehner
    Division of Cytopathology, Department of Pathology, University of California, San Francisco Medical Center, Mount Zion Campus, 1600 Divisadero Street, Box 1656, San Francisco, California 94143 1656, USA
    Acta Cytol 47:275-80. 2003
  3. pmc Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo
    Catherine C Park
    Departments of Radiation Oncology and Pathology, University of California San Francisco Mt Zion Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    Cancer Res 66:1526-35. 2006
  4. ncbi Breast cancer growth prevention by statins
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mt Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA
    Cancer Res 66:8707-14. 2006
  5. ncbi Bladder cancer outcome and subtype classification by gene expression
    Ekaterini Blaveri
    Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 0808, USA
    Clin Cancer Res 11:4044-55. 2005
  6. ncbi Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, USA
    J Clin Oncol 24:4565-9. 2006
  7. ncbi Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Soonmyung Paik
    Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 24:3726-34. 2006
  8. pmc Genes and pathways downstream of telomerase in melanoma metastasis
    Sepideh Bagheri
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 103:11306-11. 2006
  9. ncbi Fine needle aspiration cytology of adult perineal rhabdomyosarcoma: a case report
    Maxwell V Meng
    Department of Urology, University of California, San Francisco, USA
    Acta Cytol 50:88-92. 2006
  10. ncbi A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Soonmyung Paik
    Division of Pathology, Operation Center, and the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh 15212, USA
    N Engl J Med 351:2817-26. 2004

Collaborators

  • Yamei Zhou
  • Michael J Campbell
  • Taesung Park
  • Stanley P Leong
  • Maxwell V Meng
  • Christopher Haqq
  • Mohammed Kashani-Sabet
  • Soonmyung Paik
  • Jane Fridlyand
  • E A Perez
  • Javier Rangel
  • Lori J Goldstein
  • Mehdi Nosrati
  • Catherine C Park
  • Joe W Gray
  • Sima Torabian
  • Sepideh Bagheri
  • Richard W Sagebiel
  • Richard M Neve
  • Sandy Devries
  • Frederic M Waldman
  • Ekaterini Blaveri
  • Barrett H Childs
  • Sunil Badve
  • Carl Yoshizawa
  • Steve Rowley
  • Joseph A Sparano
  • Lawrence N Shulman
  • Silvana Martino
  • Robert Gray
  • George W Sledge
  • Peter M Ravdin
  • Nancy E Davidson
  • Steven Shak
  • Jennifer Yeh
  • Michael D Johnson
  • Donna G Albertson
  • Elizabeth H Blackburn
  • Stephen Ethier
  • Scot Federman
  • Maria Pallavicini
  • Paul T Spellman
  • Ladan Shaikh
  • Frances Tong
  • Koei Chin
  • Jean Philippe Coppe
  • Mina J Bissell
  • Chong J Park
  • Nora Bayani
  • Shang Li
  • Sylvia Fong
  • James R Miller
  • Frank McCormick
  • Marc Lippman
  • Dan H Moore
  • Jackie L Stilwell
  • Rebecca R Laposa
  • Nick J Wang
  • Laura Clark
  • Robert J Debs
  • Hui Zhang
  • Daniel Pinkel
  • Wen Lin Kuo
  • Terry Speed
  • Tea Fevr
  • Adi Gazdar
  • James E Cleaver
  • Robert B Dickson
  • Anna Lapuk
  • Jeff P Simko
  • Theresa Koppie
  • Sunanda Pejavar
  • Kshama Mehta
  • Peter Carroll
  • James E Korkola
  • Jeremy L Brewer

Detail Information

Publications12

  1. ncbi Metastatic balloon cell melanoma: a case report
    Frederick L Baehner
    Division of Cytopathology, University of California, San Francisco 94115, USA
    Acta Cytol 49:543-8. 2005
    ....
  2. ncbi Fine needle aspiration cytology of intraoral epithelioid hemangioma. A report of two cases
    Frederick Baehner
    Division of Cytopathology, Department of Pathology, University of California, San Francisco Medical Center, Mount Zion Campus, 1600 Divisadero Street, Box 1656, San Francisco, California 94143 1656, USA
    Acta Cytol 47:275-80. 2003
    ..In contrast to the histopathology of this lesion, the cytopathology, as obtained by fine needle aspiration biopsy (FNAB), has been described only once before...
  3. pmc Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo
    Catherine C Park
    Departments of Radiation Oncology and Pathology, University of California San Francisco Mt Zion Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1708, USA
    Cancer Res 66:1526-35. 2006
    ..Our findings indicate that beta(1) integrin is a promising therapeutic target, and that the three-dimensional lrECM culture assay can be used to effectively distinguish malignant and normal tissue response to therapy...
  4. ncbi Breast cancer growth prevention by statins
    Michael J Campbell
    Department of Surgery, University of California San Francisco Mt Zion Medical Center, Room C342, 1600 Divisadero, San Francisco, CA 94115, USA
    Cancer Res 66:8707-14. 2006
    ..These findings provide supporting rationale for future statin trials in breast cancer patients...
  5. ncbi Bladder cancer outcome and subtype classification by gene expression
    Ekaterini Blaveri
    Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 0808, USA
    Clin Cancer Res 11:4044-55. 2005
    ..Genes driving the separation between tumor subsets may prove to be important biomarkers for bladder cancer development and progression and eventually candidates for therapeutic targeting...
  6. ncbi Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, USA
    J Clin Oncol 24:4565-9. 2006
    ..To assess the prognostic significance of nuclear receptor coactivator-3 (NCOA3) overexpression in primary cutaneous melanoma...
  7. ncbi Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    Soonmyung Paik
    Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 24:3726-34. 2006
    ..The relationship between the RS and chemotherapy benefit is not known...
  8. pmc Genes and pathways downstream of telomerase in melanoma metastasis
    Sepideh Bagheri
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 103:11306-11. 2006
    ..These studies have important implications for understanding the mechanisms by which telomerase promotes tumor invasion and metastasis...
  9. ncbi Fine needle aspiration cytology of adult perineal rhabdomyosarcoma: a case report
    Maxwell V Meng
    Department of Urology, University of California, San Francisco, USA
    Acta Cytol 50:88-92. 2006
    ..Fewer than 30 cases have been reported, and all were diagnosed after surgical resection by histologic examination. Below we report a case in which the diagnosis was established preoperatively by fine needle aspiration (FNA)...
  10. ncbi A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Soonmyung Paik
    Division of Pathology, Operation Center, and the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh 15212, USA
    N Engl J Med 351:2817-26. 2004
    ..The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen-receptor-positive tumors is poorly defined by clinical and histopathological measures...
  11. pmc A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
    Richard M Neve
    Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94270, USA
    Cancer Cell 10:515-27. 2006
    ..We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify molecular features that predict or indicate response to targeted therapies or other physiological perturbations...
  12. pmc Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
    Lori J Goldstein
    Eastern Cooperative Oncology Group, Boston, MA, USA
    J Clin Oncol 26:4063-71. 2008
    ..Genomic classifiers offer the potential to more accurately identify individuals who benefit from chemotherapy than clinicopathologic features...